Paper Details

  1. Home
  2. Paper Details

Comparison of 3-drug versus 4-drug and PI versus non-PI combinations as initial HAART: experience from 1998 to 2007.

Author: BrowningSteven R, BushHeather, GreenbergRichard N, JhaveriMalhar A, ThorntonAlice

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study found that 3-drug highly active antiretroviral therapy (HAART) was as effective as 4-drug HAART in achieving a viral load <400 copies/mL at the end of a year of HAART. Failures were due to side effects (50%), nonadherence (45%), and drug allergy (5%).
Paper Details　
Original Abstract of the Article :
Although established in controlled studies that there is no advantage to 4-drug highly active antiretroviral therapy (HAART) or regimens with or without protease inhibitors (PIs), we questioned this finding in a clinical setting (ie, no inclusion criteria). Ours is a single clinic retrospective stud...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/1545109709345666

データ提供：米国国立医学図書館（NLM）

Navigating the Desert of HIV Treatment: A Comparative Study

This research takes us on a journey through the desert of HIV treatment, exploring the effectiveness of different highly active antiretroviral therapy (HAART) regimens. The study compares the outcomes of 3-drug versus 4-drug HAART and PI-containing versus non-PI-containing regimens. This is like exploring different routes through the desert, seeking the most effective path towards viral suppression.

3-Drug HAART: A Reliable Route in the Desert

The study's findings support the current guidelines recommending 3-drug HAART, suggesting that 4-drug HAART does not offer any significant advantages. This is like finding a well-trodden path in the desert, offering a reliable and effective route for navigating the challenges of HIV treatment. The research highlights the importance of considering treatment regimens based on evidence-based guidelines.

Understanding the Factors Influencing Treatment Success

The study also identifies factors that influence the success of HAART, including patient adherence and the presence of side effects. This is like understanding the different obstacles that may arise during a journey through the desert – some can be overcome with careful planning and preparation, while others may require adjustments to the route. By understanding these factors, we can improve the effectiveness of HIV treatment and provide patients with the best possible care.

Dr. Camel's Conclusion

This research delves into the desert of HIV treatment, exploring the effectiveness of different highly active antiretroviral therapy (HAART) regimens. The study's findings support current guidelines recommending 3-drug HAART, highlighting the importance of evidence-based decision-making in the complex landscape of HIV treatment. By understanding the factors that influence treatment success and developing individualized approaches, we can navigate the challenging terrain of HIV care with greater expertise and compassion, providing patients with the best possible support and care.

Date :
  1. Date Completed 2010-01-26
  2. Date Revised 2022-08-11
Further Info :

Pubmed ID

19759256

DOI: Digital Object Identifier

10.1177/1545109709345666

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.